ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,301.42
      0.08%
      US Tech 100
      18,102.40
      0.13%
      Dow Jones
      39,907.60
      0.10%
      Brent Oil
      83.28
      0.09%
      Bitcoin
      66,537.80
      1.99%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Nevro Corp (NVRO)

      7. Nevro Corp (NVRO) News

      NVRO

      Nevro (NVRO)

      Nevro Corp
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:NVRO
      DateTimeSourceHeadlineSymbolCompany
      05/09/20244:52PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
      05/09/20244:05PMPR Newswire (US)Nevro to Present at BofA Securities 2024 Healthcare ConferenceNYSE:NVRONevro Corp
      05/07/20244:56PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NVRONevro Corp
      05/07/20244:11PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
      05/07/20244:05PMPR Newswire (US)Nevro Reports First-Quarter 2024 Financial ResultsNYSE:NVRONevro Corp
      04/17/20248:30AMPR Newswire (US)Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024NYSE:NVRONevro Corp
      03/11/20244:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/11/20244:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/11/20244:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/11/20244:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/11/20244:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/06/20246:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/05/20244:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/05/20244:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/05/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/01/20245:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/01/20245:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      02/28/20244:10PMPR Newswire (US)Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral ScrewNYSE:NVRONevro Corp
      02/23/20245:08PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:NVRONevro Corp
      02/22/20244:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      02/22/20244:16PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NVRONevro Corp
      02/21/20244:11PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
      02/21/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
      02/21/20244:06PMPR Newswire (US)Nevro Enters Into Cooperation Agreement With Engaged CapitalNYSE:NVRONevro Corp
      02/21/20244:05PMPR Newswire (US)Nevro Reports Fourth-Quarter and Full-Year 2023 Financial ResultsNYSE:NVRONevro Corp
      02/14/20243:47PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:NVRONevro Corp
      02/14/20243:38PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:NVRONevro Corp
      02/01/20244:30PMPR Newswire (US)Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic NeuropathyNYSE:NVRONevro Corp
      01/29/20244:30PMPR Newswire (US)Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024NYSE:NVRONevro Corp
      01/18/20244:15PMPR Newswire (US)Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic NeuropathyNYSE:NVRONevro Corp
       Showing the most relevant articles for your search:NYSE:NVRO

      Your Recent History

      LATK
      ETMETH
      Elitecoin
      NASDAQ
      DCFC
      Tritium DCFC
      Delayed Upgrade Clock